MindImmune Therapeutics, Inc.

MindImmune Therapeutics, Inc.

 

MindImmune Therapeutics, Inc. is a pharmaceutical company developing first-in-class drugs that target the immune system to treat diseases of the central nervous system, including: Alzheimer’s, Huntington’s disease, pain, and psychiatric disorders.

It is increasingly clear that the central nervous system and the immune system are intimately integrated. Consequently, immune system dysfunction is a critical, often causative, factor in brain dysfunction. MindImmune scientists are at the forefront in recognizing the therapeutic opportunities in targeting the immune system to treat brain disease.